No abstract available
MeSH terms
-
Aged, 80 and over
-
Antibodies / blood
-
Anticoagulants / adverse effects*
-
Blood Platelets / drug effects
-
Blood Platelets / pathology
-
Dalteparin / adverse effects*
-
Female
-
Fondaparinux
-
Hip Fractures / blood
-
Hip Fractures / pathology
-
Hirudins
-
Humans
-
Immunoglobulins, Intravenous / therapeutic use*
-
Immunologic Factors / therapeutic use*
-
Morpholines / therapeutic use
-
Peptide Fragments / therapeutic use
-
Platelet Count
-
Polysaccharides / adverse effects*
-
Recombinant Proteins / therapeutic use
-
Rivaroxaban
-
Thiophenes / therapeutic use
-
Thrombocytopenia / blood
-
Thrombocytopenia / chemically induced
-
Thrombocytopenia / drug therapy
-
Thrombocytopenia / pathology*
-
Venous Thrombosis / blood
-
Venous Thrombosis / pathology
-
Venous Thrombosis / prevention & control
Substances
-
Antibodies
-
Anticoagulants
-
Hirudins
-
Immunoglobulins, Intravenous
-
Immunologic Factors
-
Morpholines
-
Peptide Fragments
-
Polysaccharides
-
Recombinant Proteins
-
Thiophenes
-
Rivaroxaban
-
Fondaparinux
-
Dalteparin
-
bivalirudin